SHL Telemedicine completes capital increase, raises CHF 35 million – Invitation to SGM for increase of authorized capital

Tel Aviv / Zurich, December 17, 2020 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions, announced today that it has entered into a share purchase agreement to raise proceeds totaling CHF 35 million via the placement of 3,588,889 shares from authorised capital (the “New Shares”) and of 300,000 treasury shares (together with the New Shares, the “Placement Shares”) by way of private placement. Following the placement, the number of SHL shares issued will increase by about 33% to 14,467,380. The Placement Shares will be issued at a price per share of CHF 9.00. For each two ordinary shares issued to a purchaser, the Company has granted the purchaser an option for a period of 24 months to purchase one ordinary share at a price per share of CHF 11.00.